Both in Pharmaceuticals
Enanta Pharmaceuticals vs ARS Pharmaceuticals
Over the past year ENTA returned +10.3% and SPRY returned −61.1%; their daily moves had a correlation of 0.25.
ENTA +10.3% SPRY −61.1%Growth of $1, one year, split-adjusted
| Metric | ENTA | SPRY |
|---|---|---|
| Price | $11.55 | $3.65 |
| Market cap | $336.4M | $363.0M |
| Today | −5.17% | −2.14% |
| 1 month | −8.6% | −17.0% |
| 6 months | −16.7% | −53.4% |
| Year to date | −26.8% | −68.7% |
| 1 year | +10.0% | −61.8% |
| Revenue growth (YoY) | −21.6% | +114.2% |
| Gross margin | 100.0% | 61.8% |
| Net margin | −135.8% | −185.2% |
| P/E (TTM) | — | — |
| Price / sales | 5.2× | 3.1× |
| Net cash | $189.5M | -$27.8M |
| Dividend yield | — | — |
| Volatility (60d) | 44.8% | 70.6% |
| Short % of float | 8.2% | 40.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).